Cargando…
Genetic Insights into the Impact of Complement in Alzheimer’s Disease
The presence of complement activation products at sites of pathology in post-mortem Alzheimer’s disease (AD) brains is well known. Recent evidence from genome-wide association studies (GWAS), combined with the demonstration that complement activation is pivotal in synapse loss in AD, strongly implic...
Autores principales: | Torvell, Megan, Carpanini, Sarah M., Daskoulidou, Nikoleta, Byrne, Robert A. J., Sims, Rebecca, Morgan, B. Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702080/ https://www.ncbi.nlm.nih.gov/pubmed/34946939 http://dx.doi.org/10.3390/genes12121990 |
Ejemplares similares
-
The Impact of Complement Genes on the Risk of Late-Onset Alzheimer’s Disease
por: Carpanini, Sarah M., et al.
Publicado: (2021) -
Terminal complement pathway activation drives synaptic loss in Alzheimer’s disease models
por: Carpanini, Sarah M., et al.
Publicado: (2022) -
Novel Monoclonal Antibodies Against Mouse C1q: Characterisation and Development of a Quantitative ELISA for Mouse C1q
por: Byrne, Robert A. J., et al.
Publicado: (2021) -
Alzheimer’s disease-associated complement gene variants influence plasma complement protein levels
por: Veteleanu, Aurora, et al.
Publicado: (2023) -
Therapeutic Inhibition of the Complement System in Diseases of the Central Nervous System
por: Carpanini, Sarah M., et al.
Publicado: (2019)